Related Experiment Video

Updated: May 18, 2026

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

Prognostic implications of progressive cardiac conduction disease

Tamiro Kawaguchi1, Hideki Hayashi, Akashi Miyamoto

  • 1Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu 520-2192, Japan.

Circulation Journal : Official Journal of the Japanese Circulation Society
|September 29, 2012
PubMed

Insights

Progressive cardiac conduction disease (PCCD) severity, indicated by increasing PR interval and QRS duration, significantly predicts heart failure hospitalization and cardiovascular death. This finding highlights the prognostic value of monitoring ECG changes in patients with PCCD.

Area of Science:

  • Cardiology
  • Electrocardiography
  • Clinical Research

Background:

  • Progressive cardiac conduction disease (PCCD) involves a worsening PR interval and QRS duration.
  • The underlying pathophysiological mechanisms of PCCD are diverse.
  • The association between PCCD progression and adverse cardiovascular outcomes requires further investigation.

Purpose of the Study:

  • To determine if progressive cardiac conduction disease (PCCD) is linked to an increased risk of cardiovascular morbidity and mortality.
  • To assess the prognostic value of temporal ECG changes in patients with PCCD.

Main Methods:

  • Utilized digital analysis of 359,737 12-lead ECGs to identify patients with PCCD.
  • Enrolled 458 patients with PCCD in a hospital-based cohort for long-term follow-up (mean 13.3 years).
  • Employed multivariate Cox proportional hazards analysis to evaluate associations between ECG parameters and outcomes.

Main Results:

  • A temporal increase in PR interval (≥ 2 ms/year) and QRS duration (≥ 3 ms/year) was significantly associated with heart failure hospitalization.
  • Higher rates of PR interval increase (≥ 4 ms/year) and QRS duration increase (≥ 5 ms/year) were significantly linked to cardiovascular mortality.
  • The study identified specific thresholds for ECG changes indicating increased risk.

Conclusions:

  • The severity of progressive cardiac conduction disease (PCCD) is an independent predictor of heart failure hospitalization.
  • Worsening PCCD is significantly associated with an increased risk of cardiovascular mortality.
  • Monitoring the rate of change in PR interval and QRS duration on ECG is crucial for risk stratification in PCCD patients.
Abstract

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...